Clinical Trial Update: A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 study of DKN-01 in multiple myeloma or advanced solid tumors has completed enrollment with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• DKN-01 (dkn-01)

Snippet

Sponsor: Leap Therapeutics, Inc. | Conditions: Multiple Myeloma, Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2016-09-28